Skip to main content Skip to section navigation Skip to footer

Vyant Bio, Inc.

  • Investors
  • Overview
  • News & Events
    • Overview
    • Press Releases
    • In the News
    • IR Calendar
    • Email Alerts
  • Company Info
    • Overview
    • Management Team
    • Contacts
    • FAQ
  • Documents
    • Presentations
    • Scientific Documents
    • Videos
  • Financial Info
    • Overview
    • Financial Results
    • Income Statement
    • Balance Sheet
    • Cash Flow
    • OTC Disclosure Statements
  • Stock Data
    • Quote
    • Charts
    • Historical Data
    • Analyst Coverage
  • SEC Filings
    • Overview
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Overview
    • Board of Directors
    • Board Committees
    • Governance Documents
    • Board Diversity Matrix

Press Releases

News & Events

News & Events

  • Overview
  • Press Releases
  • In the News
  • IR Calendar
  • Email Alerts
Sep 20, 2023 1:00pm EDT

Vyant Bio Announces Adjournment of Special Meeting of Stockholders

Jul 17, 2023 7:00am EDT

AxoSim Enters Into a Definitive Agreement to Acquire Vyant Bio's StemoniX Assets

May 12, 2023 8:00am EDT

Vyant Bio Announces Last Day of Trading on Nasdaq and Filing of Form 15 for Voluntary Nasdaq Delisting and SEC Deregistration

May 04, 2023 4:30pm EDT

Vyant Bio Announces Filing of Form 25 for Voluntary Nasdaq Delisting and SEC Deregistration

Apr 24, 2023 4:50pm EDT

Vyant Bio Announces Voluntary Nasdaq Delisting and SEC Deregistration

Feb 03, 2023 6:00am EST

Vyant Bio Commences a Cash Preservation Plan Including a Reduction in Force

Jan 04, 2023 4:15pm EST

Vyant Bio Engages LifeSci Capital to Explore Strategic Alternatives

Nov 16, 2022 5:05pm EST

Vyant Bio Presents Key Takeaways from Platform and Poster Presentations at Neuroscience 2022 Hosted by the Society for Neuroscience

Nov 16, 2022 4:43pm EST

Vyant Bio Regains Compliance with Nasdaq Minimum Bid Price Requirement

Nov 15, 2022 8:00am EST

Vyant Bio Reports Third Quarter 2022 Results and Provides Strategic and Business Highlights

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • …11
  • Next
RSS
  • Email Alerts
  • Contacts
  • RSS News Feed

Contact Us

Global locations in the US, Europe, and Australia.

Twitter LinedIn
©2023 Vyant Bio, Inc. All Rights Reserved.